We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+4.43%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.26B
AUM Growth
+$119M
Cap. Flow
+$6.18M
Cap. Flow %
0.27%
Top 10 Hldgs %
23.68%
Holding
567
New
17
Increased
150
Reduced
169
Closed
110

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$4.08M
2
VZ icon
Verizon
VZ
+$3.9M
3
OXY icon
Occidental Petroleum
OXY
+$2.83M
4
ASML icon
ASML
ASML
+$2.77M
5
BA icon
Boeing
BA
+$2.47M

Top Sells

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$2.98M
2
GMED icon
Globus Medical
GMED
+$2.48M
3
NOV icon
NOV
NOV
+$2.12M
4
AGN
Allergan Inc
AGN
+$2.02M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.51M

Sector Composition

Rank Sector Weight
1 Healthcare 16.02%
2 Technology 11.84%
3 Industrials 11.53%
4 Financials 10.85%
5 Consumer Staples 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNB
201
DELISTED
Dun & Bradstreet
DNB
$835K 0.04%
7,575
+150
+2% +$15.7K
IEMG icon
202
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$834K 0.04%
16,133
+1,551
+11% +$78.7K
QQQ icon
203
Invesco QQQ Trust
QQQ
$455B
$814K 0.04%
8,664
-89
-1% -$7.94K
JWN
204
DELISTED
Nordstrom
JWN
$806K 0.04%
11,861
+43
+0.4% +$2.79K
NSC icon
205
Norfolk Southern
NSC
$78.8B
$797K 0.04%
7,740
+215
+3% +$21.1K
TWX
206
DELISTED
Time Warner Inc
TWX
$796K 0.04%
11,329
-487
-4% -$32K
KMI icon
207
Kinder Morgan
KMI
$73.1B
$779K 0.03%
21,472
+12,830
+148% +$433K
SRCL
208
DELISTED
Stericycle Inc
SRCL
$745K 0.03%
6,295
-70
-1% -$8.01K
SO icon
209
Southern Company
SO
$110B
$724K 0.03%
15,949
+150
+0.9% +$6.63K
BAC icon
210
Bank of America
BAC
$435B
$717K 0.03%
46,651
-663
-1% -$10.3K
BBBY
211
DELISTED
Bed Bath & Beyond Inc
BBBY
$713K 0.03%
12,431
-9,300
-43% -$580K
LBTYK icon
212
Liberty Global Class C
LBTYK
$3.27B
$708K 0.03%
20,690
+14,259
+222% +$472K
MKL icon
213
Markel Group
MKL
$25B
$696K 0.03%
1,061
ACN icon
214
Accenture
ACN
$89.9B
$687K 0.03%
8,497
+572
+7% +$45.9K
DD icon
215
DuPont de Nemours
DD
$18.6B
$669K 0.03%
5,134
-49
-0.9% -$6.24K
TWC
216
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$666K 0.03%
4,523
-2
-0% -$281
IOO icon
217
iShares Global 100 ETF
IOO
$8.56B
$664K 0.03%
16,864
AAP icon
218
Advance Auto Parts
AAP
$3.37B
$661K 0.03%
4,900
EOG icon
219
EOG Resources
EOG
$78B
$655K 0.03%
5,606
+6
+0.1% +$631
CME icon
220
CME Group
CME
$92.2B
$652K 0.03%
9,190
-435
-5% -$30.6K
MDT icon
221
Medtronic
MDT
$107B
$645K 0.03%
10,123
-355
-3% -$21.6K
MSCI icon
222
MSCI
MSCI
$40B
$638K 0.03%
13,910
-215
-2% -$9.26K
ZBH icon
223
Zimmer Biomet
ZBH
$17.7B
$609K 0.03%
6,039
ED icon
224
Consolidated Edison
ED
$41.6B
$598K 0.03%
10,350
-125
-1% -$6.98K
BDX icon
225
Becton Dickinson
BDX
$43.1B
$597K 0.03%
5,169
+4
+0.1% +$454

Similar funds

Gofen & Glossberg's Q2 2014 Portfolio in Review

As of Q2 2014, Gofen & Glossberg held 567 positions worth $2.26B, up 5.5% from $2.15B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Gofen & Glossberg's Q2 2014 filing shows 17 new, 150 increased, 169 reduced and 110 closed positions. Its largest new stake was Splunk Inc: 35,720 shares worth $1.98M. The largest sale was Vodafone, an estimated $2.98M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

  • Gofen & Glossberg's largest Q2 2014 buy was Splunk Inc: 35,720 shares worth $1.98M.
  • Gofen & Glossberg added most to Perrigo in Q2 2014, an estimated $4.08M increase.
  • Gofen & Glossberg's biggest Q2 2014 reduction was Vodafone, cutting an estimated $2.98M.
  • Gofen & Glossberg fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $722K.
  • Gofen & Glossberg's ten largest holdings make up 24% of its $2.26B portfolio in Q2 2014.
  • Gofen & Glossberg opened 17 new positions and closed 110 in Q2 2014.
  • Gofen & Glossberg's portfolio value rose 5.5% quarter-over-quarter to $2.26B.

Based on Gofen & Glossberg's 13F filing for Q2 2014, filed 15 Jul 2014.